• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

2.440 -0.150 (-5.79%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,226,857
Open 2.560
Bid (Size) 2.420 (100)
Ask (Size) 2.440 (9,800)
Prev. Close 2.590
Today's Range 2.320 - 2.710
52wk Range 0.5400 - 4.000
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Wondering what's happening in today's after-hours session? ↗
December 17, 2025
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
December 17, 2025
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+3.8%
+3.8%
1 Month
+318.8%
+318.8%
3 Month
+47.9%
+47.9%
6 Month
+74.3%
+74.3%
1 Year
+3.8%
+3.8%

More News

Read More
News headline image
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
December 17, 2025
Via Chartmill
Why Did BEAT Stock Rocket 72% In Pre-Market Today? ↗
December 10, 2025
Via Stocktwits
News headline image
What's going on in today's pre-market session ↗
December 17, 2025
Via Chartmill
News headline image
Unusual volume stocks in Friday's session ↗
December 12, 2025
Via Chartmill
News headline image
Top movers analysis one hour before the close of the markets on 2025-12-11: top gainers and losers in today's session. ↗
December 11, 2025
Via Chartmill
News headline image
Curious about the most active stocks on Thursday? ↗
December 11, 2025
Via Chartmill
News headline image
Top stock movements in today's session. ↗
December 11, 2025
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
December 10, 2025
Via Chartmill
News headline image
These stocks are moving in today's session ↗
December 10, 2025
Via Chartmill
News headline image
Most active stocks in Wednesday's session ↗
December 10, 2025
Via Chartmill
News headline image
Game-Changing News: BEAT, APRE, TOON, MNTS, PRSO, PNPNF, SIGL – Stocks Under $1 Look Now
December 10, 2025
Via AB Newswire
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
December 10, 2025
Via Chartmill
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
December 10, 2025
Via Chartmill
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
December 10, 2025
Via Investor Brand Network
Topics Intellectual Property
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
December 10, 2025
Via Chartmill
News headline image
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
December 10, 2025
From HeartBeam, Inc.
Via Business Wire
News headline image
Unusual volume stocks are being observed in Monday's session. ↗
December 01, 2025
Via Chartmill
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
December 01, 2025
Via Investor Brand Network
Topics Intellectual Property
News headline image
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
November 28, 2025
Via Chartmill
News headline image
Top stock movements in today's session. ↗
November 28, 2025
Via Chartmill
News headline image
Friday's session: most active stocks ↗
November 28, 2025
Via Chartmill
News headline image
Unusual volume stocks are being observed in Friday's session. ↗
November 28, 2025
Via Chartmill
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
November 28, 2025
Via Chartmill

Frequently Asked Questions

Is Heartbeam, Inc. - Common Stock publicly traded?
Yes, Heartbeam, Inc. - Common Stock is publicly traded.
What exchange does Heartbeam, Inc. - Common Stock trade on?
Heartbeam, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heartbeam, Inc. - Common Stock?
The ticker symbol for Heartbeam, Inc. - Common Stock is BEAT on the Nasdaq Stock Market
What is the current price of Heartbeam, Inc. - Common Stock?
The current price of Heartbeam, Inc. - Common Stock is 2.440
When was Heartbeam, Inc. - Common Stock last traded?
The last trade of Heartbeam, Inc. - Common Stock was at 12/26/25 04:00 PM ET
What is the market capitalization of Heartbeam, Inc. - Common Stock?
The market capitalization of Heartbeam, Inc. - Common Stock is 83.60M
How many shares of Heartbeam, Inc. - Common Stock are outstanding?
Heartbeam, Inc. - Common Stock has 84M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap